| VXRT Snapshot | |
|---|---|
| Vaxart, Inc., a clinical-stage biotechnology company, is dedicated to the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California. | |
| VALUATION DATA | |
| Market Capitalization | $150,582,000 | Price to Sales | 0.00 |
| Earnings per Share | $-0.5700 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $0.8423 |
| 52 Week High | $21.44 |
| 52 Week Low | $2.751 |
| 50-Day Moving Average | $18.89 |
| 200-Day Moving Average | $-1.932 |
| All data are from Alpha Vantage as of today. For more infomation on VXRT see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search